Skip to main content

Trasylol Linked to Renal Failure and Death

By February 26, 2008July 17th, 2019Drug Safety

Trasylol the anti-bleeding drug used during heart surgery is more likely to cause patients to die, according to two new studies published last week in The New England Journal of Medicine.
The first study involved 10,000 patients who had bypasses at Duke University Medical Center from 1996 through 2005. It found that 6.4 percent of patients who were given Trasylol died within 30 days of the surgery, a rate nearly 2.5 times higher than patients who got another drug or who received no treatment for bleeding.
The second study looked at about 78,000 patients nationwide from 2003 to 2006. Researchers found the risk of death was 64 percent higher in the Trasylol group than in those taking another drug.
Made by Bayer, Trasylol received approval from the Food and Drug Administration in 1993. Last year, a Canadian study was stopped because of deaths among patients taking Trasylol. Reacting to the reports of higher deaths and the increased risk of serious kidney damage, the FDA requested that it be taken off the market last November.
The lawyers of Carey, Danis & Lowe are experienced in helping people injured by a dangerous prescription drug. We will seek compensation for past and future medical expenses, past and future wages, pain and suffering, disability and other damages. We also represent family members in wrongful death cases.
We offer a free initial consultation for victims of dangerous medications. If you cannot make it to our office, we will come to you at the hospital or your home.
Contact the lawyers at Carey, Danis & Lowe today by calling 877-678-3400.